Losartan Potassium, an angiotensin II receptor blocker (ARB) widely prescribed for hypertension and cardiovascular conditions, remains one of the most actively traded pharmaceutical APIs and finished dosage forms in the global market. With the Losartan Potassium tablets market estimated at USD 2.82 billion in 2026 and projected to reach USD 4.47 billion by 2033 at a CAGR of 6.8%, understanding the global buyer landscape is essential for suppliers, manufacturers, and traders seeking to expand their reach. This comprehensive guide presents a curated Losartan Potassium global buyers list, regional import analysis, and actionable strategies for connecting with verified pharmaceutical buyers. Global Losartan Potassium Market Overview The global Losartan Potassium market demonstrates…